SFS
BHVN

Sowell Financial Services’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Sowell Financial Services’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,221
Closed -$86K – 3238
2021
Q1 		$86K Sell
1,221
-197
-14% -$15.9K ﹤0.01% 1434
2020
Q4 		$122K Buy
1,418
+120
+9% +$10.2K 0.01% 1074
2020
Q3 		$84K Sell
1,298
-878
-40% -$57.5K ﹤0.01% 1044
2020
Q2 		$159K Buy
2,176
+1,250
+135% +$66.5K 0.01% 804
2020
Q1 		$32K Sell
926
-359
-28% -$16.4K ﹤0.01% 1224
2019
Q4 		$70K Buy
1,285
+1,045
+435% +$51.7K 0.01% 1032
2019
Q3 		$10K Buy
+240
New +$10.1K ﹤0.01% 1551

Other funds holding BHVN

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $153M AUM 42.86% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $501B AUM 22.01% 1-Year Est. Return